Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taurolock for prevention of central venous catheter infection in dialysis patients
IRCT2016020221066N2Phase 2Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of taurolidine in chronic kidney disease (CKD) and central venous catheter-related bloodstream infection (CRBSI), sponsored by Kermanshah University of Medical Sciences. Started Apr 2016; status: completed.
02
Drugs
taurolidine
03
Conditions
chronic kidney disease (CKD)central venous catheter-related bloodstream infection (CRBSI)
Beyond the preview
Go deeper on IRCT2016020221066N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016020221066N2.